News

July 9, 2020
Researchers have demonstrated that a new mapping approach based on near infrared spectroscopy can distinguish between fat and muscle tissue in the heart. This distinction is critical when using radiofrequency ablation to treat a serious heart rhythm problem known as ventricular tachycardia.
July 8, 2020
VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, announces the completion of a €32 million Series B financing round.
July 8, 2020
Cardurion Pharmaceuticals, Inc., a Boston-based, clinical-stag
July 7, 2020
CVRx, Inc., a private medical device company with a novel technology that treats patients suffering from chronic heart failure (HF) and resistant hypertension, announced that it raised $50 million to close its latest round of equity financing. Proceeds from the financing will be used to support commercialization of the BAROSTIM NEO in the United States.
July 7, 2020
Next Generation ICM Offers Remote Programming with Improved Longevity and Enhanced Accuracy
July 7, 2020
Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the company's next-generation Gallant™ implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices.
July 6, 2020
More studies show how COVID-19 aftermath survival may be driven by heart conditions across all…
July 6, 2020
Researchers from the Moscow Institute of Physics and Technology, Kazan Federal University, and George Washington University have proposed an algorithm for producing patient-specific mathematical models describing the electrical excitation of human heart cells.
July 2, 2020
inHEART, providing a cloud-based medical image analysis solution for cardiac interventions on patients with arrhythmias, has closed a round of EUR 3.7 million led by Elaia. These funds will be used to accelerate commercial development in Europe, access the U.S.